Page 96 - Memoria SEHH 2022

MEMORIA ANUAL 2022 SOCIEDAD ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
PETHEMA
FUNDACIÓN ESPAÑOLA DE HEMATOLOGÍA Y HEMOTERAPIA
• Isatuximab in Combination with Lenalidomide and Dexamethasone in Patients with High-Risk Smoldering Multiple Myeloma: Updated Safety Run-in Results from the Randomized Phase 3 Ithaca Study.
64th American Society of Hematology Annual Meeting and Exposition 2022 (ASH 2022). New Orleans, LA, USA: 10-13 Dec 2022. Hybrid event.
Mateos MV, Rodríguez Otero P, Koh Y, Martínez-López J, Parmar G, Prince HM, Quach H, Ribas P, Hermansen E, Hungría VTM, Besisik SK, Kim JS, Leleu X, Pečeliūnas V, Schjesvold F, Sevindik OG, Lavrova T, Dubin F, Devisme C, Lepine L, Macé S, Morisse M, Ghobrial I . Grupo de trabajo coautor: GEM .
• Identification of Molecular Mechanisms Governing CAR-T Cell Response in MM Pa- tients Using Single Cell Transcriptomics.
64th American Society of Hematology Annual Meeting and Exposition 2022 (ASH 2022). New Orleans, LA, USA: 10-13 Dec 2022. Hybrid event.
Jordana-Urriza L, Serrano G, Calleja-Cervantes ME, San Martín-Uriz P, Vilas-Zornoza A, Ullate-Agote A, Zabaleta A, Alignani D, Lozano T, Cabañas V, Navarro-Bailón A, Oliver- Caldes A, Español-Rego M, Pascal M, Juan M, Urbano-Ispizua A, Reguera JL, Moraleda JM, Mateos MV, Sánchez-Guijo F, Alfonso Piérola A, Rifón Roca JJ, Rodríguez-Otero P, Fernández de Larrea C, Paiva B, Inogés S, López-Díaz de Cerio A, Lasarte JJ, San-Miguel J, Rodríguez-Madoz JR, Hernáez M, Prósper F .
Grupo de trabajo coautor: GEM .
• BCMA CAR-T Cell Phenotype and Functionality Is Affected By Disease Stage of Mul- tiple Myeloma Patients.
64th American Society of Hematology Annual Meeting and Exposition 2022 (ASH 2022). New Orleans, LA, USA: 10-13 Dec 2022. Hybrid event.
Martín-Mallo A, Calleja-Cervantes ME, San Martín-Uriz P, Vilas-Zornoza A, Zabaleta A, Alignani D, Rodríguez-Márquez P, Rodríguez-Díaz S, Martínez-Turrillas R, Jáuregui P, Cal- viño C, Palacios-Berraquero ML, Ceballos C, Illarramendi Esteban J, Gabaldón Limas DG, Viguria MC, Redondo AM, Juan M, Urbano-Ispizua A, Fernández de Larrea C, Rodríguez- Otero P, Rifón Roca JJ, Alfonso Piérola A, Lozano T, Lasarte JJ, Paiva B, Inogés S, López- Díaz de Cerio A, San-Miguel J, Rodríguez-Madoz JR, Prósper F .
Grupo de trabajo coautor: GEM .
• Curative Strategy (GEM-CESAR) for High-Risk Smoldering Myeloma (SMM): Post-Hoc Analysis of Sustained Undetectable Measurable Residual Disease (MRD).
64th American Society of Hematology Annual Meeting and Exposition 2022 (ASH 2022). New Orleans, LA, USA: 10-13 Dec 2022. Hybrid event.
Mateos MV, Martínez-López J, Rodríguez-Otero P, San-Miguel J, González-Calle V, 96